CAR-T therapy reaches historic milestone - Quintiles
CAR-T therapy reaches historic milestone - Quintiles
The oncology world achieved an incredible gain last month, when the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) unanimously recommended approval of Novartis’ CTL019 (tisagenlecleucel), a groundbreaking chimeric antigen receptor T cell (CAR-T) therapy for the treat...
Posted by Евгений Балакин on 17 авг 2017, 19:33